Status:
COMPLETED
Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
Lead Sponsor:
Pfizer
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-75 years
Brief Summary
Tools known as 'depression scales 'are widely used as assessments to evaluate a patient's response to treatment. The purpose of this study is the evaluation of the remission rates for patients with MD...
Detailed Description
12 weeks random
Eligibility Criteria
Inclusion
- Outpatients
- 18-75 years old
- Patients diagnosed with MDD according to DSM IV without psychotic symptoms
- HAM-D17 \> or = 18 on inclusion
- Patients receiving treatment for the first time or changing treatment based on their doctor's decision
Exclusion
- Subjects with potentially problematic compliance
- Subjects participating in an interventional trial within the last 3 months
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
851 Patients enrolled
Trial Details
Trial ID
NCT00770289
Start Date
May 1 2008
End Date
December 1 2009
Last Update
August 31 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Haidari, Athens, Greece, 12461
2
Pfizer Investigational Site
Haidari, Athens, Greece, 12462
3
Pfizer Investigational Site
Ilissia, Athens, Greece, 11528